Equities

Meihua International Medical Technologies Co Ltd

MHUA:NMQ

Meihua International Medical Technologies Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.02
  • Today's Change-0.015 / -1.46%
  • Shares traded78.97k
  • 1 Year change-52.79%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Meihua International Medical Technologies Co Ltd is a holding company mainly engaged in the research, development, manufacturing and sales of Class I, Class II and Class III disposable medical devices. The Company's products include self-manufactured and out-sourced products. Class I disposable medical devices include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene (LDPE) bottles for eye drops, high-density polyethylene (HDPE) bottles for tablets, and others. Class II disposable medical devices include disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, and others. Class III disposable medical devices include disposable infusion pumps, anesthesia puncture kits, electronic pumps, and others.

  • Revenue in USD (TTM)97.10m
  • Net income in USD11.63m
  • Incorporated--
  • Employees617.00
  • Location
    Meihua International Medical Technologies Co Ltd88 Tongda RoadTouqiao Town, Guangling DistrictYANGZHOU 225000ChinaCHN
  • Websitehttp://meihuamed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Inspira Technologies Oxy BHN Ltd0.00-11.29m23.23m37.00--3.44-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
IR-Med Inc0.00-3.47m24.05m6.00--66.22-----0.0499-0.04990.000.00510.00----0.00-197.95---273.36--------------0.3019-------3.70------
Orgenesis Inc662.00k-29.02m25.81m146.00------38.99-0.8684-0.86840.02-0.33030.027278.295.384,534.25-122.18---1,312.10---101.06---4,489.28--0.0741-5.85-----98.53-50.94-271.82---17.71--
Femasys Inc950.09k-16.69m26.01m32.00--2.31--27.38-0.8468-0.84680.04720.50600.05490.34387.6529,690.31-96.51---108.58--65.67---1,756.83--5.93-77.250.2972---11.13---25.04------
Meihua International Medical Tech Co Ltd97.10m11.63m26.22m617.002.120.16852.170.2700.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
Retractable Technologies Inc38.25m-18.10m26.91m148.00--0.3158--0.7035-0.6046-0.60461.282.850.22021.446.42258,468.00-10.2812.45-10.7914.5119.1940.82-46.7118.096.54-2.860.016---54.025.55-249.46--17.42--
Ekso Bionics Holdings Inc18.16m-12.42m26.99m70.00--1.91--1.49-0.7909-0.79091.130.65380.59571.653.14259,428.60-40.75-43.63-57.60-57.6751.8351.93-68.41-104.241.77-23.990.3172--41.5710.03-0.7825--3.69--
bioAffinity Technologies Inc7.32m-8.74m27.12m75.00--6.73--3.71-0.9007-0.90070.74390.29890.9422236.818.6897,545.07-112.51---140.58--35.47---119.41--1.14-296.510.234--52,660.42--2.66------
Positron Corp1.24m-1.27m27.23m22.00------22.01-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Golden Valley Development Inc0.00-92.53k27.36m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
Neuronetics Inc72.07m-32.47m28.70m203.00--1.47--0.3983-1.10-1.102.450.64330.73092.314.76355,000.00-32.93-28.02-42.47-34.7375.9175.73-45.06-51.042.37-3.920.755--9.426.2218.76--18.57--
Neuroone Medical Technologies Corp3.96m-12.10m28.81m16.00--8.65--7.27-0.4916-0.49160.15930.10820.74281.6919.31247,702.50-226.84-172.88-334.70-274.7429.60---305.37-674.971.36--0.00--62.66---18.60------
Know Labs Inc0.00-16.34m29.68m15.00---------0.2204-0.22040.00-0.05330.00----0.00-442.53-209.16---1,087.76-------1,302.62---15.986.21---100.00---1.85---3.64--
DarioHealth Corp19.15m-46.52m30.03m223.00--0.4411--1.57-1.51-1.510.58032.270.162.393.3169,373.19-42.46-73.26-47.52-87.5930.9729.54-265.33-293.541.96--0.2961---26.4122.450.5091--52.42--
Data as of Sep 20 2024. Currency figures normalised to Meihua International Medical Technologies Co Ltd's reporting currency: US Dollar USD

Institutional shareholders

2.81%Per cent of shares held by top holders
HolderShares% Held
Anson Funds Management LPas of 30 Jun 2024648.60k2.55%
Renaissance Technologies LLCas of 30 Jun 202424.30k0.10%
UBS Securities LLCas of 30 Jun 202422.73k0.09%
Geode Capital Management LLCas of 30 Jun 202416.75k0.07%
Morgan Stanley & Co. LLCas of 30 Jun 20242.79k0.01%
XTX Markets LLCas of 30 Jun 20240.000.00%
Marshall Wace LLPas of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.